BILL ANALYSIS �
-----------------------------------------------------------------
|SENATE RULES COMMITTEE | ACR 39|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
-----------------------------------------------------------------
THIRD READING
Bill No: ACR 39
Author: Perea (D), et al.
Amended: 5/20/13 in Assembly
Vote: Majority
ASSEMBLY FLOOR : Read and adopted, 5/20/13
SUBJECT : American Cancer Society Day
SOURCE : Author
DIGEST : This resolution designates May 22, 2013, as Fight
Against Cancer Day and recognizes the American Cancer Societys
100 years of fighting cancer.
ANALYSIS :
This resolution makes the following legislative findings:
1.The American Cancer Society, originally named the American
Society for the Control of Cancer, was established in 1913 and
has 100 years of milestones in the fight against cancer.
2.In 1944, the American Cancer Society prioritized the funding
of cancer research and has, to date, funded 46 Nobel Laureates
and is the largest nongovernmental, not-for-profit funding
source of cancer research.
3.Relay For Life was launched by an American Cancer Society
volunteer in 1985 and is now the largest grassroots
CONTINUED
ACR 39
Page
2
fundraising event in the world, having raised over $3 billion
to date and raising $400 million annually to fund cancer
research, education, advocacy, and service for cancer
patients.
4.In 2006, for the first time in history, the actual number of
cancer deaths in the United States declined thanks in large
part to the American Cancer Society's groundbreaking and
tireless work in cancer prevention, early detection, and
treatment.
5.In 2012, the American Cancer Society reported that cancer
death rates had declined by 20% over the last 20 years, which
is the equivalent of 1.2 million lives saved.
This resolution designates May 22, 2013, as Fight Against Cancer
Day and recognizes the American Cancer Society's 100 years of
fighting cancer.
FISCAL EFFECT : Fiscal Com.: No
JL:nl 5/29/13 Senate Floor Analyses
SUPPORT/OPPOSITION: NONE RECEIVED
**** END ****